THE EFFECT OF RENAL FUNCTION ON INCIDENCE OF CONGESTIVE HEART FAILURE: THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) STUDY

被引：0
|
作者：
Kholghi, Maedeh Khayyat [1 ]
Oparil, Suzanne [1 ]
Davis, Barry [1 ]
Tereshchenko, Larisa G. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1157-072
引用
收藏
页码：752 / 752
页数：1
相关论文
共 50 条
  • [1] Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Piller, L
    Ford, C
    Davis, B
    Nwachuku, C
    Black, H
    Oparil, S
    Gappy, S
    Retta, T
    Probstfield, J
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 92A - 92A
  • [2] Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Practical implications
    Oparil, S
    [J]. HYPERTENSION, 2003, 41 (05) : 1006 - 1009
  • [3] Antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: Interim results
    Davis, B
    Furberg, CD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) : 325 - 325
  • [4] Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Pressel, S
    Davis, BR
    Louis, GT
    Whelton, P
    Adrogue, H
    Egan, D
    Farber, M
    Payne, G
    Probstfield, J
    Ward, H
    [J]. CONTROLLED CLINICAL TRIALS, 2001, 22 (06): : 674 - 686
  • [5] Review of heart failure events in the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT): ALLHAT heart failure validation study
    Einhorn, P
    Davis, B
    Piller, L
    deLeon, B
    Simpson, L
    Kostis, J
    Levy, D
    Massie, B
    Nwachuku, C
    Black, H
    Cushman, W
    [J]. CIRCULATION, 2003, 108 (17) : 399 - 400
  • [6] Heart failure with preserved and impaired left ventricular systolic function in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Davis, Barry R.
    Simpson, Lara M.
    Black, Henry R.
    Cushman, Wililam C.
    Einhorn, Paula T.
    Farber, Michael A.
    Ford, Charles E.
    Levy, Daniel
    Massie, Barry M.
    Nawaz, Shah
    Nawaz, Shah
    [J]. CIRCULATION, 2006, 114 (18) : 571 - 571
  • [7] Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease
    Dewland, Thomas A.
    Soliman, Elsayed Z.
    Davis, Barry R.
    Magnani, Jared W.
    Yamal, Jose-Miguel
    Piller, Linda B.
    Haywood, L. Julian
    Alonso, Alvaro
    Albert, Christine M.
    Marcus, Gregory M.
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (08) : 1085 - 1092
  • [8] Heart failure results in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Davis, B
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [9] Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Dhruva, Sanket S.
    Huang, Chenxi
    Spatz, Erica S.
    Coppi, Andreas C.
    Warner, Frederick
    Li, Shu-Xia
    Lin, Haiqun
    Xu, Xiao
    Furberg, Curt D.
    Davis, Barry R.
    Pressel, Sara L.
    Coifman, Ronald R.
    Krumholz, Harlan M.
    [J]. HYPERTENSION, 2017, 70 (01) : 94 - 102
  • [10] Blood pressure control in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Cushman, WC
    Ford, CE
    Cutler, JA
    Margolis, KL
    Davis, BR
    Grimm, RH
    [J]. CIRCULATION, 2002, 106 (19) : 476 - 476
12345